ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 653625 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 653625; 2) Community: the network communities that were significantly associated with the response to NSC 653625; 3) Molecule: the relationships between components within communities and NSC 653625; 4) MDR: the compounds that were significantly associated with the NSC 653625.

NSC Compound Enrichment Correlation
NSC 726217 Combretastatin A4-analogue 0.0217366743178497 0.16161101
NSC 740357 Null 0.0217366743178497 -0.056249195
NSC 743532 Null 0.0217366743178497 0.29270537
NSC 748902 [(20S)-20-(N,N-dimethylamino)- 3a-(tigloylamino)-5a-preg-2a-ol] 0.0217366743178497 0.44786745
NSC 750050 Null 0.0217366743178497 0.21861588
NSC 753377 3-[2-(1-methyl-1H-indol-3-yl)-1,3-thiazol-4-yl]-1-methyl-1H-pyrrolo[2,3-b]pyridine 0.0217366743178497 -0.033622458
NSC 753456 2-4-[5-(3,5-dimethoxyphenyl)-1H-1-imidazolyl]phenyl-5,6,7-trimethoxy-1,3-benzothiazole 0.0217366743178497 0.33231877
NSC 755442 Null 0.0217366743178497 0.2943564
NSC 761832 (Z)-3-((1-(3,5-dimethoxyphenyl)-9H-pyrido[3,4-b]indol-3-yl)methylene)-5-methoxyindolin-2-one 0.0217366743178497 0.26839426
NSC 85561 3-hydroxy-4-((1-hydroxynaphthalen-2-yl)diazenyl)-7-nitronaphthalene-1-sulfonic acid, sodium sallt 0.0217366743178497 0.12422518
Total:128  Current:65    [First] [Prev] [Next] [Last]